Commissioners told to slash hospital spend on high-cost drugs

GP commissioners must urgently bring 'accelerating' hospital spend on high-cost drugs under control, the DH has warned.

Spending: GP commissioners urged to cut hospital drug costs
Spending: GP commissioners urged to cut hospital drug costs

The department said the NHS may be wasting millions of pounds a year because hospitals and providers are not incentivised to cut the cost of drugs that fall outside of the Payment by Results tariff.

Ministers want GP commissioners to work with hospitals to reduce the bill for high-cost ‘homecare’ treatments, which now cost the NHS at least £1.25bn. This figure is rising by 20% per year.

But last year University Hospital Southampton NHS Foundation Trust saved around £4m by reviewing its homecare spending, suggesting similar efforts across the NHS could save hundreds of millions of pounds.

Homecare treatments are hospital-prescribed medicines supplied directly to patients’ homes. Prices are negotiated locally because they fall outside of the national Payment by Results tariff.

But a DH report produced as part of the NHS efficiency savings drive suggested the NHS may be wasting money ‘paying for more expensive treatments where equally effective but cheaper alternatives are available’. It said this may be due to the lack of a financial incentive for commissioners and providers to reduce treatment costs.

The DH has appointed Mark Hackett, chief executive of University Hospital Southampton and author of a 2011 report into homecare medicines, to lead a project aiming ‘to maximise efficiency and value for NHS budgets’ relating to homecare treatments.

In a letter to hospital chiefs, he warned that these costs are set to accelerate unless the NHS takes action.

He added: ‘We will be seeking to engage with clinical commissioning groups (CCGs) to ensure that these efficiencies are maximised in 2013/14.’

The DH says the report will help commissioners and providers when ensuring patients can access NICE-approved treatments under the NHS Constitution.

Earlier this year a GP magazine investigation found the NHS may fail to hit efficiency targets because hospitals' efforts to control drug spending are decades behind those in primary care.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Professor Dame Clare Gerada elected RCGP president

Professor Dame Clare Gerada elected RCGP president

London GP Professor Dame Clare Gerada will become the new president of the RCGP,...

GPs lead COVID-19 vaccine drive as jabs stall in younger adults

GPs lead COVID-19 vaccine drive as jabs stall in younger adults

GPs have urged young people to come forward for COVID-19 vaccination with jab uptake...

GPs leading PCNs report heavy workload and limited impact from ARRS

GPs leading PCNs report heavy workload and limited impact from ARRS

PCN clinical directors are facing burnout and struggling to develop their networks...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

RCGP online exhibition celebrates women in general practice

RCGP online exhibition celebrates women in general practice

An online exhibition celebrating women’s contribution to general practice over the...

MPs back campaign against reforms that 'threaten fairness of fitness to practise cases'

MPs back campaign against reforms that 'threaten fairness of fitness to practise cases'

Plans to scrap the 'five-year rule' and categorise doctors with health concerns as...